(Q39231005)

English

Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells

scientific article published on 5 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells (English)

1 reference

Europe PubMed Central

10 September 2017

1 reference

based on heuristic

inferred from title

invasive ductal carcinoma

1 reference

based on heuristic

inferred from title

pancreatic ductal adenocarcinoma

1 reference

based on heuristic

inferred from title

pancreatic ductal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hirotaka Kanzaki

1

1 reference

Europe PubMed Central

10 September 2017

Akashi Ohtaki

2

1 reference

Europe PubMed Central

10 September 2017

Faisal K Merchant

3

1 reference

Europe PubMed Central

10 September 2017

Mark I Greene

4

1 reference

Europe PubMed Central

10 September 2017

Ramachandran Murali

5

1 reference

Europe PubMed Central

10 September 2017

publication date

5 December 2012

1 reference

Europe PubMed Central

10 September 2017

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

10 September 2017

94

1 reference

Europe PubMed Central

10 September 2017

2

1 reference

Europe PubMed Central

10 September 2017

372-379

1 reference

Europe PubMed Central

10 September 2017

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Osteoprotegerin (OPG)-a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Regulation of the immune response to antigens on the malignant cell surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

BH3 mimetic obatoclax enhances TRAIL-mediated apoptosis in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Ras activity levels control the development of pancreatic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Regulation of cancer cell migration and bone metastasis by RANKL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

TRAIL upregulates decoy receptor 1 and mediates resistance to apoptosis in insulin-secreting INS-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

The role of K-ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Epidemiology of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

TRAIL and its receptors as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Role of full-length osteoprotegerin in tumor cell biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.11.003

7 January 2021

Identifiers

10.1016/J.YEXMP.2012.11.003

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39231005&oldid=1813892362"